dasatinib sandoz 70 mg filmtabletta
sandoz hungária kft. - dasatinib -
dasatinib sandoz 100 mg filmtabletta
sandoz hungária kft. - dasatinib -
dasatinib sandoz 140 mg filmtabletta
sandoz hungária kft. - dasatinib -
dasatinib teva 20 mg filmtabletta
teva b.v. - dasatinib -
dasatinib teva 50 mg filmtabletta
teva b.v. - dasatinib -
dasatinib teva 70 mg filmtabletta
teva b.v. - dasatinib -
dasatinib teva 80 mg filmtabletta
teva b.v. - dasatinib -
dasatinib teva 100 mg filmtabletta
teva b.v. - dasatinib -
lenalidomide krka d.d.
krka, d.d., novo mesto - lenalidomide hydrochloride hydrate - multiple myeloma; lymphoma, follicular; myelodysplastic syndromes - immunszuppresszánsok - multiple myelomalenalidomide krka d. as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) kezelésére javallt felnőtt betegek korábban nem kezelt, myeloma multiplex, akik nem jogosultak transzplantációs. lenalidomide krka d. in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka d. as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. follicular lymphomalenalidomide krka d. in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).
dasatinib krka 20 mg filmtabletta
krka d.d., - dasatinib -